{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T20:12:22Z","timestamp":1769112742755,"version":"3.49.0"},"reference-count":39,"publisher":"MDPI AG","issue":"23","license":[{"start":{"date-parts":[[2020,12,7]],"date-time":"2020-12-07T00:00:00Z","timestamp":1607299200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100011019","name":"Nemzeti Kutat\u00e1si Fejleszt\u00e9si \u00e9s Innov\u00e1ci\u00f3s Hivatal","doi-asserted-by":"publisher","award":["NKFIH-1150-6\/2019"],"award-info":[{"award-number":["NKFIH-1150-6\/2019"]}],"id":[{"id":"10.13039\/501100011019","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015269","name":"Magyarorsz\u00e1g Korm\u00e1nya","doi-asserted-by":"publisher","award":["\u00daNKP-19-3"],"award-info":[{"award-number":["\u00daNKP-19-3"]}],"id":[{"id":"10.13039\/501100015269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015269","name":"Magyarorsz\u00e1g Korm\u00e1nya","doi-asserted-by":"publisher","award":["GINOP-2.3.2-15-2016-00043"],"award-info":[{"award-number":["GINOP-2.3.2-15-2016-00043"]}],"id":[{"id":"10.13039\/501100015269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015269","name":"Magyarorsz\u00e1g Korm\u00e1nya","doi-asserted-by":"publisher","award":["EFOP-3.6.1-16-2016-00022"],"award-info":[{"award-number":["EFOP-3.6.1-16-2016-00022"]}],"id":[{"id":"10.13039\/501100015269","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecules"],"abstract":"<jats:p>Hematological and oncological disorders represent leading causes of childhood mortality. Neuropeptide somatostatin (SST) has been previously demonstrated in various pediatric tumors, but limited information exists on the expression and characteristics of SST receptors (SSTR) in hematological and oncological disorders of children. We aimed to investigate the expression of mRNA for SSTR subtypes (SSTR-1\u20135) in 15 pediatric hematological\/oncological specimens by RT-PCR. The presence and binding characteristics of SSTRs were further studies by ligand competition assay. Our results show that the pediatric tumor samples highly expressed mRNA for the five SSTR subtypes with various patterns. The mRNA for SSTR-2 was detected in all specimens independently of their histological type. A Hodgkin lymphoma sample co-expressed mRNA for all five SSTR subtypes. SSTR-3 and SSTR-5 were detected only in malignant specimens, such as rhabdomyosarcoma, Hodgkin lymphoma, acute lymphoblastic leukemia, and a single nonmalignant condition, hereditary spherocytosis. The incidence of SSTR-1 and SSTR-4 was similar (60%) in the 15 specimens investigated. Radioligand binding studies demonstrated the presence of specific SSTRs and high affinity binding of SST analogs in pediatric solid tumors investigated. The high incidence of SSTRs in hematological and oncological disorders in children supports the merit of further investigation of SSTRs as molecular targets for diagnosis and therapy.<\/jats:p>","DOI":"10.3390\/molecules25235775","type":"journal-article","created":{"date-parts":[[2020,12,10]],"date-time":"2020-12-10T22:15:36Z","timestamp":1607638536000},"page":"5775","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Expression of Somatostatin Receptor Subtypes (SSTR-1\u2013SSTR-5) in Pediatric Hematological and Oncological Disorders"],"prefix":"10.3390","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5181-0693","authenticated-orcid":false,"given":"Kristof","family":"Harda","sequence":"first","affiliation":[{"name":"Department of Biopharmacy, Faculty of Pharmacy, University of Debrecen, 4032 Debrecen, Hungary"},{"name":"Doctoral School of Pharmaceutical Sciences, University of Debrecen, 4032 Debrecen, Hungary"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4838-4210","authenticated-orcid":false,"given":"Zsuzsanna","family":"Szabo","sequence":"additional","affiliation":[{"name":"Department of Biopharmacy, Faculty of Pharmacy, University of Debrecen, 4032 Debrecen, Hungary"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Juhasz","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Faculty of Medicine, University of Debrecen, 4032 Debrecen, Hungary"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Balazs","family":"Dezso","sequence":"additional","affiliation":[{"name":"Department of Pathology, Faculty of Medicine, University of Debrecen, 4032 Debrecen, Hungary"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5170-5965","authenticated-orcid":false,"given":"Csongor","family":"Kiss","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Faculty of Medicine, University of Debrecen, 4032 Debrecen, Hungary"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew V.","family":"Schally","sequence":"additional","affiliation":[{"name":"Veterans Affairs Medical Center, Endocrine, Polypeptide and Cancer Institute, Miami, FL 33125, USA"},{"name":"Department of Pathology, Miller School of Medicine, University of Miami, Miami, FL 33101, USA"},{"name":"Department of Medicine, Divisions of Hematology-Oncology and Endocrinology, Miller School of Medicine, University of Miami, Miami, FL 33101, USA"},{"name":"Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL 33136, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabor","family":"Halmos","sequence":"additional","affiliation":[{"name":"Department of Biopharmacy, Faculty of Pharmacy, University of Debrecen, 4032 Debrecen, Hungary"},{"name":"Veterans Affairs Medical Center, Endocrine, Polypeptide and Cancer Institute, Miami, FL 33125, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2020,12,7]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"238","DOI":"10.5507\/bp.2015.058","article-title":"Expression profiles of somatostatin, dopamine, and estrogen receptors in pituitary adenomas determined by means of synthetic multilocus calibrators","volume":"160","author":"Drastikova","year":"2016","journal-title":"Biomed. Pap."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0960-0760(92)90184-K","article-title":"Somatostatin receptors in human cancer: Incidence, characteristics, functional correlates and clinical implications","volume":"43","author":"Reubi","year":"1992","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1111\/j.1582-4934.2010.01125_1.x","article-title":"Somatostatin receptor biology in neuroendocrine and pituitary tumours: Part 2\u2014Clinical implications","volume":"14","author":"Cakir","year":"2010","journal-title":"J. Cell. Mol. Med."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Schally, A.V., and Halmos, G. (2012). Targeting to peptide receptors. Drug Delivery in Oncology, Wiley-VCH Verlag GmbH & Co. KGaA.","DOI":"10.1002\/9783527634057.ch38"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Harda, K., Szabo, Z., Szabo, E., Olah, G., Fodor, K., Szasz, C., Mehes, G., Schally, A.V., and Halmos, G. (2018). Somatostatin receptors as molecular targets in human uveal melanoma. Molecules, 23.","DOI":"10.3390\/molecules23071535"},{"key":"ref_6","first-page":"2564","article-title":"High expression of somatostatin receptors and messenger ribonucleic acid for its receptor subtypes in organ-confined and locally advanced human prostate cancers","volume":"85","author":"Halmos","year":"2000","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1006\/frne.2001.0217","article-title":"Hypothalamic hormones and cancer","volume":"22","author":"Schally","year":"2001","journal-title":"Front. Neuroendocr."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"3509","DOI":"10.1210\/jcem.85.10.3509","article-title":"Human ovarian cancers express somatostatin receptors","volume":"85","author":"Halmos","year":"2000","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0026-0495(96)90077-3","article-title":"Somatostatin receptors and their subtypes in human tumors and in peritumoral vessels","volume":"45","author":"Reubi","year":"1996","journal-title":"Metabolism"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/0024-3205(95)02082-T","article-title":"The somatostatin receptor family","volume":"57","author":"Patel","year":"1995","journal-title":"Life Sci."},{"key":"ref_11","first-page":"427","article-title":"Molecular biology of somatostatin receptors","volume":"16","author":"Reisine","year":"1995","journal-title":"Endocr. Rev."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/S1043-2760(97)00168-9","article-title":"Somatostatin Receptors","volume":"8","author":"Patel","year":"1997","journal-title":"Trends Endocrinol. Metab."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1093\/annonc\/mdl105","article-title":"Rationale for the use of somatostatin analogs as antitumor agents","volume":"17","author":"Susini","year":"2006","journal-title":"Ann. Oncol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2814","DOI":"10.1210\/endo.135.6.7988476","article-title":"Subtype selectivity of peptide analogs for all five cloned human somatostatin receptors (hsstr 1\u20135)","volume":"135","author":"Patel","year":"1994","journal-title":"Endocrinology"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1007\/BF03350317","article-title":"Molecular pharmacology of somatostatin receptor subtypes","volume":"20","author":"Patel","year":"1997","journal-title":"J. Endocrinol. Investig."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Gomes-Porras, M., C\u00e1rdenas-Salas, J., and \u00c1lvarez-Escol\u00e1, C. (2020). Somatostatin Analogs in Clinical Practice: A Review. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21051682"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"3785","DOI":"10.1523\/JNEUROSCI.20-10-03785.2000","article-title":"Distribution, targeting, and internalization of the sst4 somatostatin receptor in rat brain","volume":"20","author":"Schreff","year":"2000","journal-title":"J. Neurosci."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.3892\/ol.2013.1584","article-title":"Solitary infantile myofibromatosis in the bones of the upper extremities: Two rare cases and a review of the literature","volume":"6","author":"Wu","year":"2013","journal-title":"Oncol. Lett."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.jaad.2014.03.035","article-title":"Infantile myofibromatosis: A series of 28 cases","volume":"71","author":"Mashiah","year":"2014","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1590\/abd1806-4841.20175001","article-title":"Infantile myofibromatosis","volume":"92","author":"Larralde","year":"2017","journal-title":"An. Bras. Dermatol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.jormas.2017.11.018","article-title":"Agressive pediatric myofibromatosis in a two-year-old child","volume":"119","author":"Letelier","year":"2018","journal-title":"J. Stomatol. Oral Maxillofac. Surg."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0165-5876(00)00288-3","article-title":"Nasopharyngeal teratomas and dermoids: A review of the literature and case series","volume":"52","author":"Coppit","year":"2000","journal-title":"Int. J. Pediatric Otorhinolaryngol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1148\/rg.251045156","article-title":"From the archives of the afip: A comprehensive review of fetal tumors with pathologic correlation","volume":"25","author":"Woodward","year":"2005","journal-title":"Radiographics"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"4218","DOI":"10.1002\/cncr.24465","article-title":"Trends in childhood rhabdomyosarcoma incidence and survival in the united states, 1975\u20132005","volume":"115","author":"Ognjanovic","year":"2009","journal-title":"Cancer"},{"key":"ref_25","first-page":"23","article-title":"Topics in pediatric leukemia\u2014Acute lymphoblastic leukemia","volume":"7","author":"Esparza","year":"2005","journal-title":"Medscape Gen. Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3389\/fonc.2014.00054","article-title":"Current concepts in pediatric philadelphia chromosome-positive acute lymphoblastic leukemia","volume":"4","author":"Bernt","year":"2014","journal-title":"Front. Oncol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21551","article-title":"Cancer statistics, 2019","volume":"69","author":"Siegel","year":"2019","journal-title":"CA A Cancer J. Clin."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"81","DOI":"10.6004\/jnccn.2020.0001","article-title":"Pediatric acute lymphoblastic leukemia, version 2.2020, nccn clinical practice guidelines in oncology","volume":"18","author":"Brown","year":"2020","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1136\/adc.2006.094706","article-title":"The investigation and management of chronic neutropenia in children","volume":"91","author":"James","year":"2006","journal-title":"Arch. Dis. Child."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/bjh.14677","article-title":"How I manage children with neutropenia","volume":"178","author":"Dale","year":"2017","journal-title":"Br. J. Haematol."},{"key":"ref_31","unstructured":"Gresh, R. (2019). Overview of pediatric cancer. MSD Manual, Nemours\/Alfred I. duPont Hospital for Children."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1056\/NEJMoa1915315","article-title":"Rituximab for high-risk, mature b-cell non-hodgkin\u2019s lymphoma in children","volume":"382","author":"Auperin","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/s41598-019-57172-6","article-title":"Somatostatin receptor mediated targeting of acute myeloid leukemia by photodynamic metal complexes for light induced apoptosis","volume":"10","author":"Vegi","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"e1281","DOI":"10.1097\/MD.0000000000001281","article-title":"Somatostatin Receptor SSTR-2a Expression Is a Stronger Predictor for Survival Than Ki-67 in Pancreatic Neuroendocrine Tumors","volume":"94","author":"Mehta","year":"2015","journal-title":"Medicine"},{"key":"ref_35","first-page":"5805","article-title":"Metastatic hormone-refractory prostatic adenocarcinoma expresses somatostatin receptors and is visualized in vivo by [111in]-labeled dtpa-d-[phe1]-octreotide scintigraphy","volume":"55","author":"Nilsson","year":"1995","journal-title":"Cancer Res."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"27566","DOI":"10.18632\/oncotarget.4491","article-title":"Inverse expression of somatostatin and cxcr4 chemokine receptors in gastroenteropancreatic neuroendocrine neoplasms of different malignancy","volume":"6","author":"Kaemmerer","year":"2015","journal-title":"Oncotarget"},{"key":"ref_37","first-page":"137","article-title":"Somatostatin and somatostatin receptors","volume":"50","author":"Kumar","year":"2010","journal-title":"Results Probl. Cell Differ."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1159\/000201392","article-title":"Clinical use of somatostatin analogues in paediatric oncology","volume":"57","author":"Albers","year":"1996","journal-title":"Digestion"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.5858\/2008-132-1079-PAMLTI","article-title":"Primary and metastatic lung tumors in the pediatric population: A review and 25-year experience at a large children\u2019s hospital","volume":"132","author":"Dishop","year":"2008","journal-title":"Arch. Pathol. Lab. Med."}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/25\/23\/5775\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:42:05Z","timestamp":1760179325000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/25\/23\/5775"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,7]]},"references-count":39,"journal-issue":{"issue":"23","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["molecules25235775"],"URL":"https:\/\/doi.org\/10.3390\/molecules25235775","relation":{},"ISSN":["1420-3049"],"issn-type":[{"value":"1420-3049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,7]]}}}